From: Use of telemonitoring in patient self-management of chronic disease: a qualitative meta-synthesis
 | Section A: Are the results valid? | Section B: What are the results? | Section C: will the results help locally? | |||||||
---|---|---|---|---|---|---|---|---|---|---|
STUDY | Clear Statement of the aims? | Appropriate qualitative methodology? | Appropriate research design? | Appropriate recruitment strategy? | Appropriate data collection? | Appropriate consideration of the patient-researcher relationship? | Ethical issues taken in consideration? | Rigorous data analysis? | Clear statement of findings? | How valuable is the research? |
Baron 2017b | Y | Y | Y | CAN’T TELL | Y | CAN’T TELL | CAN’T TELL | Y | Y | Additional research is needed to identify mediators of change in this population |
Beran 2018 | Y | Y | Y | Y | Y | CAN’T TELL | CAN’T TELL | Y | Y | Investigates the relationship patient-pharmacist and clearly define the key characteristics for the successful of the intervention |
Buis 2020 | Y | Y | Y | CAN’T TELL | Y | CAN’T TELL | CAN’T TELL | Y | Y | Confirms the feasibility and acceptability of the intervention for this population. |
Grant 2019 | Y | Y | Y | Y | Y | CAN’T TELL | CAN’T TELL | Y | Y | Gives additional insights on the role of telemonitoring in BP management, showing its cost-effectiveness, easiness, and simplicity for self-management. |
Hanley 2015 | Y | Y | Y | Y | Y | CAN’T TELL | CAN’T TELL | Y | Y | Shows the beneficial effects of telemonitoring on patients self-care motivation and behaviour. |
Lee 2018 | Y | Y | Y | Y | Y | CAN’T TELL | Y | Y | Y | The findings support the use of telemonitoring for the routine care of people with type 2 diabetes. |
Lee 2019 | Y | Y | Y | Y | Y | CAN’T TELL | CAN’T TELL | Y | Y | Identification of several perceived barriers that may limit the effectiveness of telemonitoring for this population. |
Nissen 2017 | Y | Y | Y | Y | Y | CAN’T TELL | CAN’T TELL | Y | Y | Gives additional insights on the experience of telemonitoring for COPD patients with different severity of the condition. |
Pekmezaris 2020 | Y | Y | Y | CAN’T TELL | Y | CAN’T TELL | CAN’T TELL | Y | Y | Identifies important adaptation for telemonitoring interventions in this population (Hispanic/Latino). |